Company Profile
RxSight Stock Price, News & Analysis
- Ticker:
- RXST
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
5.64 USD (+8.67%)
Close
Last updated: July 27, 2026
204M USD
Market cap
Why the stock is moving
As of Jul 27, 2026, RXST closed up 8.67% at $5.64. No new same-company headline was identified in the current news window.
Company overview
Business overview
RxSight is a medical device company focused on adjustable intraocular lenses for cataract surgery. Its business is built around ophthalmic procedure adoption and premium eye-care technology.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, RxSight sits in procedure-driven medtech.
Business Model Characteristics
Revenue comes from lens sales, system adoption, and the growth of its cataract-refractive platform.
Position Within the Biotechnology Landscape
RxSight is a growth-oriented eye-care device name whose valuation depends on procedure penetration and execution.
Future catalysts
RxSight's catalysts are Light Adjustable Lens adoption and cataract-cycle execution, both of which are central to the growth story. The company’s stock tends to respond to evidence that procedure adoption is still widening.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026
DNLI · Source: Denali Therapeutics
- 02
- 03
ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call
ICUI · Source: ICU Medical
- 04
Encompass Health increases and declares dividend on common stock
EHC · Source: Encompass Health Corporation
- 05
Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026
TCMD · Source: Tactile Systems Technology, Inc.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of RxSight (RXST)?
RxSight (RXST) most recently closed at 5.64 USD, a +8.67% move versus the previous session.
What is the market cap of RxSight (RXST)?
RxSight currently has a market capitalization of 204M USD on BioPharmSignal.
What does RxSight do?
RxSight is a medical device company focused on adjustable intraocular lenses for cataract surgery. Its business is built around ophthalmic procedure adoption and premium eye-care technology.
On which exchange is RXST stock listed?
RxSight (RXST) is associated with NASDAQ, United States, Biopharma.
What is RxSight?
RxSight's catalysts are Light Adjustable Lens adoption and cataract-cycle execution, both of which are central to the growth story.
Which conditions is RxSight targeting with RxSight?
RxSight's catalysts are Light Adjustable Lens adoption and cataract-cycle execution, both of which are central to the growth story.
How does RxSight describe recent progress with RxSight?
RxSight's catalysts are Light Adjustable Lens adoption and cataract-cycle execution, both of which are central to the growth story.
What is Light?
RxSight's catalysts are Light Adjustable Lens adoption and cataract-cycle execution, both of which are central to the growth story.